Paper of the year

NOFE’s “Paper of the year” prize

The NOFE prize for Paper of the year (NOK 10 000,-) will be awarded to a first author of an epidemiologic paper which has been published with a DOI number (online or in print) in an international scientific journal from September of the previous year up to and including August this year. The paper must be based on data from Norway and affiliated with a Norwegian institution. The award will be presented at the annual NOFE conference in October/November. The deadline for submitting candidate proposals is 1^st September and should be sent to post @nofe.no. The submitter is encouraged to provide a brief justification for the nomination.

The nominated papers will be evaluated by a committee appointed by the NOFE board. Assessment criteria are: Outstanding scientific quality and integrity in a) methodologic robustness, b) presentation, and c) contribution to the field. The first author of the paper must be able to attend the conference to receive the award and present the paper. If the first author is not able to attend, it must be agreed in advance that a co-author may attend the conference to receive the award and present the paper on behalf of the first author.

____________________________________________________________________________

Vegard Svendsen

Congratulations to Vegard Svendsen for NOFEs prize for Paper of the year 2024!

The award was presented at the 30th NOFE conference in Oslo October 2024.

The winner of the paper of the year 2024 is Vegard Svendsen and co-authors with the article “Mortality in women with a history of incarceration in Norway: a 20-year national cohort study” published in the International Journal of Epidemiology in February this year.

The winning paper is well-written, delivering a clear and impactful public health message. It addresses a novel research question focused on a marginalized and under-researched population. The study exemplifies the importance of well-executed descriptive epidemiology, shedding light on a significant issue with clear potential for prevention.

Previous winners:
2023: Simon Lergenmuller and Corina S. Rueegg

Lergenmuller, Simon, et al. Lifetime sunburn trajectories and associated risks of cutaneous melanoma and squamous cell carcinoma among a cohort of Norwegian women. JAMA Dermatology (2022)

2022: Øystein Karlstad

Karlstad, Øystein, et al. SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA cardiology 7.6 (2022).

2021: Maria Brandkvist

Brandkvist, Maria, et al. Genetic associations with temporal shifts in obesity and severe obesity during the obesity epidemic in Norway: A longitudinal population-based cohort (the HUNT Study). PLoS medicine 17.12 (2020).

2020: Ben Brumpton

Brumpton, B, et al. Avoiding dynastic, assortative mating, and population stratification biases in Mendelian randomization through within-family analyses. Nat Commun 11, 3519 (2020).

2019: Ekaterina Sharashova
Sharashova E, et al. Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study. Eur Heart J 2020; 41:1554-1562

2018: Mats Julius Stensrud
Stensrud MJ, Valberg M. Inequality in genetic cancer risk suggests bad genes rather than bad luck. Nat Commun 2017; 8: 1165

2017: Paz Lopez-Doriga Ruiz
Paz LD Ruiz, et al. Pandemic Influenza A H1N1 Vaccination and Subsequent Risk of Type 1 Diabetes in Norway. Epidemiology 2018; 29: e6-e8

2016: Maria Magnus
Maria C. Magnus, et al. Infant Growth and Risk of Childhood-Onset Type 1 Diabetes in Children From 2 Scandinavian Birth Cohorts. JAMA Pediatr. 2015;169(12):e153759